Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection (Q43108142)

14 November 2017

Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection (English)

1 reference

14 November 2017

tenofovir/emtricitabine

1 reference

17

Walid Heneine

1 reference

14 November 2017

6

Silvina Masciotra

1 reference

14 November 2017

J Gerardo García-Lerma

1

1 reference

14 November 2017

Mian-er Cong

2

1 reference

14 November 2017

James Mitchell

3

1 reference

14 November 2017

Ae S Youngpairoj

4

1 reference

14 November 2017

Qi Zheng

5

1 reference

14 November 2017

Amy Martin

7

1 reference

14 November 2017

Zsuzsanna Kuklenyik

8

1 reference

14 November 2017

Angela Holder

9

1 reference

14 November 2017

Jonathan Lipscomb

10

1 reference

14 November 2017

Chou-Pong Pau

11

1 reference

14 November 2017

John R Barr

12

1 reference

14 November 2017

Debra L Hanson

13

1 reference

14 November 2017

Ron Otten

14

1 reference

14 November 2017

Lynn Paxton

15

1 reference

14 November 2017

Thomas M Folks

16

1 reference

14 November 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

Science Translational Medicine

14 November 2017

1 reference

14 November 2017

2

1 reference

14 November 2017

14

1 reference

14 November 2017

14ra4

1 reference

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

14 November 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

A preemptive strike against HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Evaluation of oral tenofovir disoproxil fumarate and topical tenofovir GS-7340 to protect infant macaques against repeated oral challenges with virulent simian immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Glycerol monolaurate prevents mucosal SIV transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Intracellular pharmacokinetics of tenofovir diphosphate, carbovir triphosphate, and lamivudine triphosphate in patients receiving triple-nucleoside regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Measurement of intracellular didanosine and tenofovir phosphorylated metabolites and possible interaction of the two drugs in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Pharmacokinetic and pharmacodynamic characteristics of emtricitabine support its once daily dosing for the treatment of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Perils at mucosal front lines for HIV and SIV and their hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Metabolism and pharmacokinetics of novel oral prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug classes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Brief but efficient: acute HIV infection and the sexual transmission of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Short Communication: A Rapid and Sensitive Real-Time PCR Assay for the K65R Drug Resistance Mutation in SIV Reverse Transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

Effect of mobile phase pH and organic content on LC-MS analysis of nucleoside and nucleotide HIV reverse transcriptase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000391

10.1126/SCITRANSLMED.3000391

21 January 2018

Identifiers

DOI

1 reference

14 November 2017

1 reference